IMMP · IMMUTEP Ltd
$0.38
-0.01 (-2.01%)
At close · Jul 24
Market Cap
$56.66M
Shares
147.37M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.38
Open$0.39
Day$0.38–0.40
52W$0.29–3.53
Avg vol 30d375K
Short int2.2M · 1.5% float · 5.3d
Short vol48%
DataJan 2020–Jul 2026
Up next
FQ1-27 quarter ends
~Sep 30, 2026
Est
Equibles Rating
blended score · not investment adviceOverall
Strong Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Limited
Quant / Vol
Very High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−75%
below
Price vs 50-day avg
−7%
below
RSI (14)
40
neutral
MACD trend
Negative
52-week position
3%
near low
Momentum
relative strength
1-month return
−6%
trailing
6-month return
−86%
trailing
YTD return
−87%
this year
Relative strength
−92%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
4 of 28 funds reported for Jun 30 · net +1.7K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.46% of float · ▼ -44.8% MoM · 5.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Squeeze score
39
low risk · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
126%
annualized · 1-yr
Max drawdown
−90%
past year
ATR
7.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−75%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
40
Neutral
MACD trend
Negative
Bearish
52-week position
3%
Bearish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
4 of 28 funds reported for Jun 30 · net +1.7K sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
1.46% of float · ▼ -44.8% MoM · 5.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
28 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $0
Now $0 · 3%
52-wk high $4
vs 200-day avg -75%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
IMMP
this stock
IMMUTEP Ltd
|
$56.66M | -86.6% | — | — | 1.5% |
|
ONC
BeOne Medicines Ltd.
|
$471.01B | +7.6% | +22179.2% | 958.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$121.16B | +4.4% | +46.2% | 28.3 | 2.0% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$68.78B | -15.4% | +20.8% | 16.0 | 3.3% |
|
ARGX
Argenx SE
|
$57.44B | +9.9% | — | — | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| IMMP | -6.2% | -6.2% | -85.9% | -8.5% | -86.6% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | -4.5% | -6.9% | -92.3% | -7.3% | -94.8% |